These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9427083)

  • 1. Effects of isotretinoin therapy on lipoprotein (a) serum levels.
    Georgala S; Schulpis KH; Potouridou I; Papadogeorgaki H
    Int J Dermatol; 1997 Nov; 36(11):863-4. PubMed ID: 9427083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in lipid and lipoprotein levels during isotretinoin treatment for acne vulgaris with special emphasis on HDL-cholesterol.
    Lestringant GG; Frossard PM; Agarwal M; Galadari IH
    Int J Dermatol; 1997 Nov; 36(11):859-62. PubMed ID: 9427082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of isotretinoin treatment on plasma holotranscobalamin, vitamin B12, folic acid, and homocysteine levels: non-controlled study.
    Karadag AS; Tutal E; Ertugrul DT; Akin KO
    Int J Dermatol; 2011 Dec; 50(12):1564-9. PubMed ID: 22098008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcome of acne vulgaris with oral isotretinoin.
    Bener A; Lestringant GG; Ehlayel MS; Saarinen K; Takiddin AH
    J Coll Physicians Surg Pak; 2009 Jan; 19(1):49-51. PubMed ID: 19149981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotretinoin treatment induces oxidative toxicity in blood of patients with acne vulgaris: a clinical pilot study.
    Erturan İ; Naziroğlu M; Akkaya VB
    Cell Biochem Funct; 2012 Oct; 30(7):552-7. PubMed ID: 22517509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-carnitine supplementation in patients with cystic acne on isotretinoin therapy.
    Georgala S; Schulpis KH; Georgala C; Michas T
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):205-9. PubMed ID: 10642057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma cholesterol and triglyceride levels after treatment with oral isotretinoin. A prospective study.
    Zech LA; Gross EG; Peck GL; Brewer HB
    Arch Dermatol; 1983 Dec; 119(12):987-93. PubMed ID: 6228196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotretinoin therapy: any need for laboratory assessment?
    Tallab T; Joharji H; Jazei M; Bahamdan K; Ibrahim K; Karkashan E
    West Afr J Med; 2004; 23(4):273-5. PubMed ID: 15730082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral isotretinoin on lipids and liver enzymes in acne patients.
    Kızılyel O; Metin MS; Elmas ÖF; Çayır Y; Aktaş A
    Cutis; 2014 Nov; 94(5):234-8. PubMed ID: 25474452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.
    Bershad S; Rubinstein A; Paterniti JR; Le NA; Poliak SC; Heller B; Ginsberg HN; Fleischmajer R; Brown WV
    N Engl J Med; 1985 Oct; 313(16):981-5. PubMed ID: 2931603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etofibrate but not controlled-release niacin decreases LDL cholesterol and lipoprotein (a) in type IIb dyslipidemic subjects.
    Sposito AC; Mansur AP; Maranhão RC; Rodrigues-Sobrinho CR; Coelho OR; Ramires JA
    Braz J Med Biol Res; 2001 Feb; 34(2):177-82. PubMed ID: 11175492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotretinoin does not prolong QT intervals and QT dispersion in patients with severe acne: a surprising finding for a drug with numerous side effects.
    Dursun R; Alpaslan M; Caliskan M; Ciftci O; Kulaksizoglu S; Seckin D; Muderrisoglu H
    J Drugs Dermatol; 2011 Jul; 10(7):710-4. PubMed ID: 21720652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tamoxifen on fibrinogen, D-dimer, lipid and lipoprotein concentrations in breast cancer patients.
    Genç S; Tanrikulu-Kiliç F; Gürdöl F; Unlüçerçi Y; Uler P; Lama A; Unur N
    Clin Chim Acta; 2003 Nov; 337(1-2):177-9. PubMed ID: 14568197
    [No Abstract]   [Full Text] [Related]  

  • 15. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin.
    Ferahbas A; Turan MT; Esel E; Utas S; Kutlugun C; Kilic CG
    J Dermatolog Treat; 2004 Jun; 15(3):153-7. PubMed ID: 15204147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of systemic administration of isotretinoin on blood lipids and fatty acids in acne patients.
    Ostlere LS; Harris D; Morse-Fisher N; Wright S
    Int J Dermatol; 1996 Mar; 35(3):216-8. PubMed ID: 8655244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome of acne vulgaris with oral isotretinoin in 89 patients.
    Ng PP; Goh CL
    Int J Dermatol; 1999 Mar; 38(3):213-6. PubMed ID: 10208621
    [No Abstract]   [Full Text] [Related]  

  • 18. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.
    Zane LT; Leyden WA; Marqueling AL; Manos MM
    Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of isotretinoin on the metabolism of triglyceride-rich lipoproteins and on the lipid profile in patients with acne.
    De Marchi MA; Maranhão RC; Brandizzi LI; Souza DR
    Arch Dermatol Res; 2006 Mar; 297(9):403-8. PubMed ID: 16429299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of isotretinoin on triglycerides and liver aminotransferases.
    Vieira AS; Beijamini V; Melchiors AC
    An Bras Dermatol; 2012; 87(3):382-7. PubMed ID: 22714752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.